Scalp dysesthesia

Archives of Dermatology

Volumn 134, Issue 3, 1998, Pages 327-330

  Hoss, Diane ^a   Segal, Samantha ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DESIPRAMINE; DOXEPIN; FLUOXETINE; GABAPENTIN; HYDROXYZINE; SERTRALINE;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DYSESTHESIA; FEMALE; HUMAN; MENTAL DISEASE; MENTAL STRESS; PAIN; PHYSICAL STRESS; PRIORITY JOURNAL; PRURITUS; SCALP; SKIN ALLERGY; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; FEMALE; HUMANS; MENTAL DISORDERS; MIDDLE AGED; PARESTHESIA; SCALP; STRESS, PSYCHOLOGICAL;

EID: 0031912402     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.3.327     Document Type: Article

References (20)

1. Cotterill JA. Dermatological non-disease: a common and potentially fatal disturbance of cutaneous body image. Br J Dermatol. 1981;104:611-619.
2. Koblenzer CS, Bostrom P. Chronic cutaneous dysesthesia syndrome: a psychotic phenomenon or a depressive symptom? J Am Acad Dermatol. 1994;30: 370-374.
3. McKay M. Vulvodynia, scrotodynia, and other chronic dysesthesias of the anogenital region (including pruritus ani). In: Bernhard JD, ed. Itch: Mechanisms and Management of Pruritus. New York, NY: McGraw-Hill Book Co; 1994:161-183.
4. Huang W, Rothe MJ, Grant-Kels JM. The burning mouth syndrome. J Am Acad Dermatol. 1996;34:91-98.
5. Aghabeigi B. The pathophysiology of pain. Br Dent J. 1992;173:91-97.
6. Sulzberger MB, Witten VH, Kopf AW. Diffuse alopecia in women. Arch Dermatol. 1960;81:108-112.
7. Venning VA, Dawber RPR. Patterned androgenic alopecia in women. J Am Acad Dermatol. 1988;18:1073-1077.
8. Headington JT. Telogen effluvium: new concepts and review. Arch Dermatol. 1993; 129:356-363.
9. Koblenzer CS. Psychocutaneous disease. In: Moschella SL, Hurley HJ, eds. Dermatology. Philadelphia, Pa: WB Saunders Co; 1992:2025-2041.
10. Lynch PJ. Vulvodynia: a syndrome of unexplained vulvar pain, psychologic disability and sexual dysfunction. J Reprod Med. 1986;31:773-780.
11. Feinmann C, Harris M, Cawley R. Psychogenic facial pain: presentation and treatment. BMJ. 1984;288:436-438.
12. Hampf G, Vikkula J, Ylipaavalniemi P, Aalberg V. Psychiatric disorders in orofacial dysaesthesia. Int J Oral Maxillofac Surg. 1987;16:402-407.
13. Bowers KE. Cutaneous and mucosal pain syndromes. Med Surg Dermatol. 1995; 2:129-132.
14. Lee R, Spencer PSJ. Antidepressants and pain: a review of the pharmacological data supporting the use of certain tricyclics in chronic pain. J Int Med Res. 1977; 5(suppl 1):146-156.
15. Feinmann C. Pain relief by antidepressants: possible modes of action. Pain. 1985; 23:1-8.
16. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 1982;32:671-673.
17. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992;326:1250-1256.
18. McKay M. Dysesthetic ('essential') vulvodynia: treatment with amitriptyline. J Reprod Med. 1993;38:9-13.
19. McGraw T, Kosek P. Erythromelalgia pain managed with gabapentin. Anesthesiology. 1997;86:988-990.
20. Mellick GA, Mellick LB. Reflex sympathetic dystrophy treated with gabapentin. Arch Phys Med Rehabil. 1997;78:98-105.